New Key Statistics Module, Z-Score and F-Score
XCNQ:BUX Key Ratios
Market Cap C$ M | 21.81 |
Enterprise Value C$ M | 22.39 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 240.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.06 |
Beneish M-Score | -4.5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -4.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -14.68 |
EV-to-EBITDA | -18.99 |
PEG | -- |
Shares Outstanding M | 90.89 |
Net Margin (%) | -1,006.79 |
Operating Margin % | -943.21 |
Pre-tax Margin (%) | -1,009.26 |
Quick Ratio | 0.14 |
Current Ratio | 0.14 |
ROA % (ttm) | -169.93 |
ROE % (ttm) | -- |
ROIC % (ttm) | -132.02 |
Dividend Yield % | -- |
Altman Z-Score | -18.70 |
XCNQ:BUX Number of Guru Trades
XCNQ:BUX Volume of Guru Trades
Gurus Latest Trades with XCNQ:BUX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:BUX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biomark Diagnostics Inc Insider Transactions
No Available Data